Global Immuno-oncology Diagnosis Market Research Report 2025(Status and Outlook)
Description
Report Overview
Immuno-oncology diagnostics refers to the specialized field of medical testing focused on identifying biomarkers, genetic mutations, and immune-related signatures that guide the diagnosis, prognosis, and treatment selection for cancer patients undergoing immunotherapy. These diagnostics encompass a range of technologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), and flow cytometry, which help detect PD-L1 expression, tumor mutational burden (TMB), microsatellite instability (MSI), and other immune checkpoint markers critical for predicting patient response to immunotherapies like checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. The field is rapidly evolving due to advancements in precision medicine, with diagnostics playing a pivotal role in stratifying patients for personalized treatment regimens, minimizing adverse effects, and improving clinical outcomes. The increasing adoption of companion diagnostics and the integration of artificial intelligence for data analysis further enhance the accuracy and efficiency of immuno-oncology testing, making it indispensable in modern oncology care.
The global Immuno-oncology Diagnosis market size was estimated at USD 12375.0 million in 2024, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Immuno-oncology Diagnosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-oncology Diagnosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-oncology Diagnosis market in any manner.
Global Immuno-oncology Diagnosis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioMérieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Market Segmentation (by Type)
PCR
NGS
Immunoassay
Market Segmentation (by Application)
Research
Diagnostics
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno-oncology Diagnosis Market
Overview of the regional outlook of the Immuno-oncology Diagnosis Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Diagnosis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno-oncology Diagnosis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Immuno-oncology diagnostics refers to the specialized field of medical testing focused on identifying biomarkers, genetic mutations, and immune-related signatures that guide the diagnosis, prognosis, and treatment selection for cancer patients undergoing immunotherapy. These diagnostics encompass a range of technologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), and flow cytometry, which help detect PD-L1 expression, tumor mutational burden (TMB), microsatellite instability (MSI), and other immune checkpoint markers critical for predicting patient response to immunotherapies like checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. The field is rapidly evolving due to advancements in precision medicine, with diagnostics playing a pivotal role in stratifying patients for personalized treatment regimens, minimizing adverse effects, and improving clinical outcomes. The increasing adoption of companion diagnostics and the integration of artificial intelligence for data analysis further enhance the accuracy and efficiency of immuno-oncology testing, making it indispensable in modern oncology care.
The global Immuno-oncology Diagnosis market size was estimated at USD 12375.0 million in 2024, exhibiting a CAGR of 12.50% during the forecast period.
This report provides a deep insight into the global Immuno-oncology Diagnosis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-oncology Diagnosis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-oncology Diagnosis market in any manner.
Global Immuno-oncology Diagnosis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioMérieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Market Segmentation (by Type)
PCR
NGS
Immunoassay
Market Segmentation (by Application)
Research
Diagnostics
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immuno-oncology Diagnosis Market
Overview of the regional outlook of the Immuno-oncology Diagnosis Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Diagnosis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno-oncology Diagnosis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
193 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Immuno-oncology Diagnosis
- 1.2 Key Market Segments
- 1.2.1 Immuno-oncology Diagnosis Segment by Type
- 1.2.2 Immuno-oncology Diagnosis Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Immuno-oncology Diagnosis Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Immuno-oncology Diagnosis Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Immuno-oncology Diagnosis Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Immuno-oncology Diagnosis Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Immuno-oncology Diagnosis Product Life Cycle
- 3.3 Global Immuno-oncology Diagnosis Sales by Manufacturers (2020-2025)
- 3.4 Global Immuno-oncology Diagnosis Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Immuno-oncology Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Immuno-oncology Diagnosis Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Immuno-oncology Diagnosis Market Competitive Situation and Trends
- 3.8.1 Immuno-oncology Diagnosis Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Immuno-oncology Diagnosis Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Immuno-oncology Diagnosis Industry Chain Analysis
- 4.1 Immuno-oncology Diagnosis Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Immuno-oncology Diagnosis Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Immuno-oncology Diagnosis Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Immuno-oncology Diagnosis Market
- 5.7 ESG Ratings of Leading Companies
- 6 Immuno-oncology Diagnosis Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Immuno-oncology Diagnosis Sales Market Share by Type (2020-2025)
- 6.3 Global Immuno-oncology Diagnosis Market Size Market Share by Type (2020-2025)
- 6.4 Global Immuno-oncology Diagnosis Price by Type (2020-2025)
- 7 Immuno-oncology Diagnosis Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Immuno-oncology Diagnosis Market Sales by Application (2020-2025)
- 7.3 Global Immuno-oncology Diagnosis Market Size (M USD) by Application (2020-2025)
- 7.4 Global Immuno-oncology Diagnosis Sales Growth Rate by Application (2020-2025)
- 8 Immuno-oncology Diagnosis Market Sales by Region
- 8.1 Global Immuno-oncology Diagnosis Sales by Region
- 8.1.1 Global Immuno-oncology Diagnosis Sales by Region
- 8.1.2 Global Immuno-oncology Diagnosis Sales Market Share by Region
- 8.2 Global Immuno-oncology Diagnosis Market Size by Region
- 8.2.1 Global Immuno-oncology Diagnosis Market Size by Region
- 8.2.2 Global Immuno-oncology Diagnosis Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Immuno-oncology Diagnosis Sales by Country
- 8.3.2 North America Immuno-oncology Diagnosis Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Immuno-oncology Diagnosis Sales by Country
- 8.4.2 Europe Immuno-oncology Diagnosis Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Immuno-oncology Diagnosis Sales by Region
- 8.5.2 Asia Pacific Immuno-oncology Diagnosis Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Immuno-oncology Diagnosis Sales by Country
- 8.6.2 South America Immuno-oncology Diagnosis Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Immuno-oncology Diagnosis Sales by Region
- 8.7.2 Middle East and Africa Immuno-oncology Diagnosis Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Immuno-oncology Diagnosis Market Production by Region
- 9.1 Global Production of Immuno-oncology Diagnosis by Region(2020-2025)
- 9.2 Global Immuno-oncology Diagnosis Revenue Market Share by Region (2020-2025)
- 9.3 Global Immuno-oncology Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Immuno-oncology Diagnosis Production
- 9.4.1 North America Immuno-oncology Diagnosis Production Growth Rate (2020-2025)
- 9.4.2 North America Immuno-oncology Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Immuno-oncology Diagnosis Production
- 9.5.1 Europe Immuno-oncology Diagnosis Production Growth Rate (2020-2025)
- 9.5.2 Europe Immuno-oncology Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Immuno-oncology Diagnosis Production (2020-2025)
- 9.6.1 Japan Immuno-oncology Diagnosis Production Growth Rate (2020-2025)
- 9.6.2 Japan Immuno-oncology Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Immuno-oncology Diagnosis Production (2020-2025)
- 9.7.1 China Immuno-oncology Diagnosis Production Growth Rate (2020-2025)
- 9.7.2 China Immuno-oncology Diagnosis Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 10x Genomics
- 10.1.1 10x Genomics Basic Information
- 10.1.2 10x Genomics Immuno-oncology Diagnosis Product Overview
- 10.1.3 10x Genomics Immuno-oncology Diagnosis Product Market Performance
- 10.1.4 10x Genomics Business Overview
- 10.1.5 10x Genomics SWOT Analysis
- 10.1.6 10x Genomics Recent Developments
- 10.2 Abbott Laboratories
- 10.2.1 Abbott Laboratories Basic Information
- 10.2.2 Abbott Laboratories Immuno-oncology Diagnosis Product Overview
- 10.2.3 Abbott Laboratories Immuno-oncology Diagnosis Product Market Performance
- 10.2.4 Abbott Laboratories Business Overview
- 10.2.5 Abbott Laboratories SWOT Analysis
- 10.2.6 Abbott Laboratories Recent Developments
- 10.3 Abcam
- 10.3.1 Abcam Basic Information
- 10.3.2 Abcam Immuno-oncology Diagnosis Product Overview
- 10.3.3 Abcam Immuno-oncology Diagnosis Product Market Performance
- 10.3.4 Abcam Business Overview
- 10.3.5 Abcam SWOT Analysis
- 10.3.6 Abcam Recent Developments
- 10.4 Adaptive Biotechnologies
- 10.4.1 Adaptive Biotechnologies Basic Information
- 10.4.2 Adaptive Biotechnologies Immuno-oncology Diagnosis Product Overview
- 10.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Product Market Performance
- 10.4.4 Adaptive Biotechnologies Business Overview
- 10.4.5 Adaptive Biotechnologies Recent Developments
- 10.5 Aethlon Medical
- 10.5.1 Aethlon Medical Basic Information
- 10.5.2 Aethlon Medical Immuno-oncology Diagnosis Product Overview
- 10.5.3 Aethlon Medical Immuno-oncology Diagnosis Product Market Performance
- 10.5.4 Aethlon Medical Business Overview
- 10.5.5 Aethlon Medical Recent Developments
- 10.6 Agena Bioscience
- 10.6.1 Agena Bioscience Basic Information
- 10.6.2 Agena Bioscience Immuno-oncology Diagnosis Product Overview
- 10.6.3 Agena Bioscience Immuno-oncology Diagnosis Product Market Performance
- 10.6.4 Agena Bioscience Business Overview
- 10.6.5 Agena Bioscience Recent Developments
- 10.7 Angle plc
- 10.7.1 Angle plc Basic Information
- 10.7.2 Angle plc Immuno-oncology Diagnosis Product Overview
- 10.7.3 Angle plc Immuno-oncology Diagnosis Product Market Performance
- 10.7.4 Angle plc Business Overview
- 10.7.5 Angle plc Recent Developments
- 10.8 Apocell
- 10.8.1 Apocell Basic Information
- 10.8.2 Apocell Immuno-oncology Diagnosis Product Overview
- 10.8.3 Apocell Immuno-oncology Diagnosis Product Market Performance
- 10.8.4 Apocell Business Overview
- 10.8.5 Apocell Recent Developments
- 10.9 ARUP Laboratories
- 10.9.1 ARUP Laboratories Basic Information
- 10.9.2 ARUP Laboratories Immuno-oncology Diagnosis Product Overview
- 10.9.3 ARUP Laboratories Immuno-oncology Diagnosis Product Market Performance
- 10.9.4 ARUP Laboratories Business Overview
- 10.9.5 ARUP Laboratories Recent Developments
- 10.10 Beckman Coulter
- 10.10.1 Beckman Coulter Basic Information
- 10.10.2 Beckman Coulter Immuno-oncology Diagnosis Product Overview
- 10.10.3 Beckman Coulter Immuno-oncology Diagnosis Product Market Performance
- 10.10.4 Beckman Coulter Business Overview
- 10.10.5 Beckman Coulter Recent Developments
- 10.11 Becton Dickinson
- 10.11.1 Becton Dickinson Basic Information
- 10.11.2 Becton Dickinson Immuno-oncology Diagnosis Product Overview
- 10.11.3 Becton Dickinson Immuno-oncology Diagnosis Product Market Performance
- 10.11.4 Becton Dickinson Business Overview
- 10.11.5 Becton Dickinson Recent Developments
- 10.12 Bioarray Genetics
- 10.12.1 Bioarray Genetics Basic Information
- 10.12.2 Bioarray Genetics Immuno-oncology Diagnosis Product Overview
- 10.12.3 Bioarray Genetics Immuno-oncology Diagnosis Product Market Performance
- 10.12.4 Bioarray Genetics Business Overview
- 10.12.5 Bioarray Genetics Recent Developments
- 10.13 BioCartis
- 10.13.1 BioCartis Basic Information
- 10.13.2 BioCartis Immuno-oncology Diagnosis Product Overview
- 10.13.3 BioCartis Immuno-oncology Diagnosis Product Market Performance
- 10.13.4 BioCartis Business Overview
- 10.13.5 BioCartis Recent Developments
- 10.14 Biocept
- 10.14.1 Biocept Basic Information
- 10.14.2 Biocept Immuno-oncology Diagnosis Product Overview
- 10.14.3 Biocept Immuno-oncology Diagnosis Product Market Performance
- 10.14.4 Biocept Business Overview
- 10.14.5 Biocept Recent Developments
- 10.15 Biodesix Inc
- 10.15.1 Biodesix Inc Basic Information
- 10.15.2 Biodesix Inc Immuno-oncology Diagnosis Product Overview
- 10.15.3 Biodesix Inc Immuno-oncology Diagnosis Product Market Performance
- 10.15.4 Biodesix Inc Business Overview
- 10.15.5 Biodesix Inc Recent Developments
- 10.16 BioFluidica
- 10.16.1 BioFluidica Basic Information
- 10.16.2 BioFluidica Immuno-oncology Diagnosis Product Overview
- 10.16.3 BioFluidica Immuno-oncology Diagnosis Product Market Performance
- 10.16.4 BioFluidica Business Overview
- 10.16.5 BioFluidica Recent Developments
- 10.17 BioGenex 40 bioMérieux
- 10.17.1 BioGenex 40 bioMérieux Basic Information
- 10.17.2 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product Overview
- 10.17.3 BioGenex 40 bioMérieux Immuno-oncology Diagnosis Product Market Performance
- 10.17.4 BioGenex 40 bioMérieux Business Overview
- 10.17.5 BioGenex 40 bioMérieux Recent Developments
- 10.18 Bio-Rad
- 10.18.1 Bio-Rad Basic Information
- 10.18.2 Bio-Rad Immuno-oncology Diagnosis Product Overview
- 10.18.3 Bio-Rad Immuno-oncology Diagnosis Product Market Performance
- 10.18.4 Bio-Rad Business Overview
- 10.18.5 Bio-Rad Recent Developments
- 10.19 Bio-Techne
- 10.19.1 Bio-Techne Basic Information
- 10.19.2 Bio-Techne Immuno-oncology Diagnosis Product Overview
- 10.19.3 Bio-Techne Immuno-oncology Diagnosis Product Market Performance
- 10.19.4 Bio-Techne Business Overview
- 10.19.5 Bio-Techne Recent Developments
- 10.20 Bristol-Myers Squibb
- 10.20.1 Bristol-Myers Squibb Basic Information
- 10.20.2 Bristol-Myers Squibb Immuno-oncology Diagnosis Product Overview
- 10.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Product Market Performance
- 10.20.4 Bristol-Myers Squibb Business Overview
- 10.20.5 Bristol-Myers Squibb Recent Developments
- 10.21 Cancer Genetics
- 10.21.1 Cancer Genetics Basic Information
- 10.21.2 Cancer Genetics Immuno-oncology Diagnosis Product Overview
- 10.21.3 Cancer Genetics Immuno-oncology Diagnosis Product Market Performance
- 10.21.4 Cancer Genetics Business Overview
- 10.21.5 Cancer Genetics Recent Developments
- 10.22 Caris Molecular Diagnostics
- 10.22.1 Caris Molecular Diagnostics Basic Information
- 10.22.2 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Overview
- 10.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Market Performance
- 10.22.4 Caris Molecular Diagnostics Business Overview
- 10.22.5 Caris Molecular Diagnostics Recent Developments
- 10.23 CellMax Life
- 10.23.1 CellMax Life Basic Information
- 10.23.2 CellMax Life Immuno-oncology Diagnosis Product Overview
- 10.23.3 CellMax Life Immuno-oncology Diagnosis Product Market Performance
- 10.23.4 CellMax Life Business Overview
- 10.23.5 CellMax Life Recent Developments
- 10.24 Charles River Laboratories
- 10.24.1 Charles River Laboratories Basic Information
- 10.24.2 Charles River Laboratories Immuno-oncology Diagnosis Product Overview
- 10.24.3 Charles River Laboratories Immuno-oncology Diagnosis Product Market Performance
- 10.24.4 Charles River Laboratories Business Overview
- 10.24.5 Charles River Laboratories Recent Developments
- 10.25 Chronix Biomedical
- 10.25.1 Chronix Biomedical Basic Information
- 10.25.2 Chronix Biomedical Immuno-oncology Diagnosis Product Overview
- 10.25.3 Chronix Biomedical Immuno-oncology Diagnosis Product Market Performance
- 10.25.4 Chronix Biomedical Business Overview
- 10.25.5 Chronix Biomedical Recent Developments
- 10.26 Circulogene
- 10.26.1 Circulogene Basic Information
- 10.26.2 Circulogene Immuno-oncology Diagnosis Product Overview
- 10.26.3 Circulogene Immuno-oncology Diagnosis Product Market Performance
- 10.26.4 Circulogene Business Overview
- 10.26.5 Circulogene Recent Developments
- 10.27 Clearbridge BioMedics
- 10.27.1 Clearbridge BioMedics Basic Information
- 10.27.2 Clearbridge BioMedics Immuno-oncology Diagnosis Product Overview
- 10.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Product Market Performance
- 10.27.4 Clearbridge BioMedics Business Overview
- 10.27.5 Clearbridge BioMedics Recent Developments
- 10.28 Clinical Genomics
- 10.28.1 Clinical Genomics Basic Information
- 10.28.2 Clinical Genomics Immuno-oncology Diagnosis Product Overview
- 10.28.3 Clinical Genomics Immuno-oncology Diagnosis Product Market Performance
- 10.28.4 Clinical Genomics Business Overview
- 10.28.5 Clinical Genomics Recent Developments
- 10.29 Pfizer
- 10.29.1 Pfizer Basic Information
- 10.29.2 Pfizer Immuno-oncology Diagnosis Product Overview
- 10.29.3 Pfizer Immuno-oncology Diagnosis Product Market Performance
- 10.29.4 Pfizer Business Overview
- 10.29.5 Pfizer Recent Developments
- 10.30 Promega
- 10.30.1 Promega Basic Information
- 10.30.2 Promega Immuno-oncology Diagnosis Product Overview
- 10.30.3 Promega Immuno-oncology Diagnosis Product Market Performance
- 10.30.4 Promega Business Overview
- 10.30.5 Promega Recent Developments
- 11 Immuno-oncology Diagnosis Market Forecast by Region
- 11.1 Global Immuno-oncology Diagnosis Market Size Forecast
- 11.2 Global Immuno-oncology Diagnosis Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Immuno-oncology Diagnosis Market Size Forecast by Country
- 11.2.3 Asia Pacific Immuno-oncology Diagnosis Market Size Forecast by Region
- 11.2.4 South America Immuno-oncology Diagnosis Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Immuno-oncology Diagnosis by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Immuno-oncology Diagnosis Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Immuno-oncology Diagnosis by Type (2026-2033)
- 12.1.2 Global Immuno-oncology Diagnosis Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Immuno-oncology Diagnosis by Type (2026-2033)
- 12.2 Global Immuno-oncology Diagnosis Market Forecast by Application (2026-2033)
- 12.2.1 Global Immuno-oncology Diagnosis Sales (K Units) Forecast by Application
- 12.2.2 Global Immuno-oncology Diagnosis Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
